Valley of Death
MPs announce the first evidence session into Bridging the Valley of Death
16 April 2012
The evidence session should allow the Committee to explore:
- the academic understanding of commercialising research and addressing the Valley of Death, thus establishing the base themes and provide context for the rest of the inquiry and
- the way in which bioscience has been commercialised, what is changing and whether there are lessons to be learned by other sectors.
- Parliament TV: Bridging the Valley of Death
- Inquiry: Bridging the Valley of Death
- Science and Technology Committee
Wednesday 18 April 2012
9.15 am in the Thatcher Room, Portcullis House
Witnesess
At 9.15 am
- Professor Luke Georghiou, Vice-President (Research and Innovation), University of Manchester
- Dr Paul Nightingale, Science and Technology Policy Research, University of Sussex
- David Connell, Senior Research Fellow, Centre for Business Research/ UK Innovation Research Centre, Judge Business School, University of Cambridge
- Dr Douglas Robertson, Chair, Praxis-Unico
At 10.15 am
- Dr. Ted Bianco, Director of Technology Transfer, Wellcome Trust
- Dr. Ian Tomlinson, Senior Vice President, Head of Worldwide Business Development and Biopharmaceuticals R&D, GlaxoSmithKline
- Dr. David Tapolczay, Chief Executive Officer, Medical Research Council Technology
- Dr. Gareth Goodier, Chair, Shelford Group (Chief Executives of ten leading Academic Medical Centres and large teaching hospitals); Chief Executive, Cambridge University Hospitals NHS Foundation Trust
- Dr. Andy Richards, Serial biotechnology entrepreneur and business angel